The expression of insulin-like growth factor-I receptor correlates with Fuhrman grading of renal cell carcinomas

Human Pathology

Volumn 35, Issue 9, 2004, Pages 1132-1136

  Ahmad, Nazeel ^a   Keehn, Connie A ^a   Coppola, Domenico ^b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b CytoCor Diagn Laboratory Services   (United States)

Author keywords

IGF I; IGF IR; insulin like growth factor I; insulin like growth factor I receptor; PBS; phosphate buffered saline; prognosis; RCC; renal cell carcinoma; tumor grading; VHL; Von Hippel Lindau

Indexed keywords

AVIDIN; BIOTIN; FORMALDEHYDE; PARAFFIN; PEROXIDASE; POLYCLONAL ANTIBODY; RECEPTOR ANTIBODY; SOMATOMEDIN C RECEPTOR;

ADULT; AGED; ARTICLE; CANCER GRADING; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KRUSKAL WALLIS TEST; MALE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SCORING SYSTEM; STAINING; STATISTICAL ANALYSIS; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, SOMATOMEDIN;

EID: 4444353881     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2004.05.012     Document Type: Article

References (53)

1. Reuter V.E., Gaudin P.B. Adult renal tumors. Sternberg S. Diagnostic Surgical Pathology. (ed 3):1999;Lippincott Williams & Wilkins, Philadelphia, PA
2. Yu M.C., Mack T.M., Hanisch R., et al. Cigarette smoking, obesity, diuretic use, and coffee consumption as risk factors for renal cell carcinoma. J Natl Cancer Inst. 77:1986;351-356
3. Mandel J.S., McLaughlin J.K., Schlehofer B., et al. International renal-cell cancer study. IV. Occupation. Int J Cancer. 61:1995;601-605
4. Mellemgaard A., Lindblad P., Schlehofer B., et al. International renal-cell cancer study. III. Role of weight, height, physical activity, and use of amphetamines. Int J Cancer. 60:1995;350-354
5. Kosary C.L., McLaughlin J.K. Kidney and renal pelvis. Miller B.A., Ries L.A.G., Hankey B.F.,, et al. SEER Cancer Statistics Review, 1970-1990. 1993;National Cancer Institute, Bethesda, MD
6. King C.R., Schimke R.N., Arthur T., et al. Proximal 3p deletion in renal cell carcinoma cells from a patient with von Hippel-Lindau disease. Cancer Genet Cytogenet. 27:1987;345-348
7. Goodman M.D., Goodman B.K., Lubin M.B., et al. Cytogenetic characterization of renal cell carcinoma in von Hippel-Lindau syndrome. Cancer. 65:1990;1150-1154
8. Datta K., Nambudripad R., Pal S., et al. Inhibition of insulin-like growth factor-I-mediated cell signaling by the von Hippel-Lindau gene product in renal cancer. J Biol Chem. 275:2000;20700-20706
9. Wang J., Zhou J., Powell-Braxton L., et al. Effects of Igf1 gene deletion on postnatal growth patterns. Endocrinology. 140:1999;3391-3394
10. Guder W.G., Schmolke M., Wirthensohn G. Carbohydrate and lipid metabolism of the renal tubule in diabetes mellitus. Eur J Clin Chem Clin Biochem. 30:1992;669-674
11. Simon D. Puberty in chronically diseased patients. Horm Res. 57:(Suppl 2):2002;53-56
12. Vijayan A., Franklin S.C., Delmez J.A., et al. Insulin-like growth factor 1 enhances renal function in a patient with chronic renal failure on peritoneal dialysis. Am J Kidney Dis. 35:2000;150-153
13. Zumkeller W., Schofield P.N. The role of insulin-like growth factors and IGF-binding proteins in the physiological and pathological processes of the kidney. Virchows Arch B. 62:1992;207-220
14. Kellerer M., von Eye Corleta H., Muhlhofer A., et al. Insulin- and insulin-like growth-factor-I receptor tyrosine-kinase activities in human renal carcinoma. Int J Cancer. 62:1995;501-507
15. Ouban A., Muraca P., Yeatman T., et al. Expression and distribution of insulin-like growth factor-1 receptor in human carcinomas. HUM PATHOL. 34:2003;803-808
16. Parker A.S., Cheville J.C., Janney C.A., et al. High expression levels of insulin-like growth factor-I receptor predict poor survival among women with clear-cell renal cell carcinomas. HUM PATHOL. 33:2002;801-805
17. Fuhrman S.A., Lasky L.C., Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 6:1982;655-663
18. Medeiros L.J., Gelb A.B., Weiss L.M. Renal cell carcinoma. Prognostic significance of morphologic parameters in 121 cases. Cancer. 61:1988;1639-1651
19. Allred D.C., Clark G.M., Elledge R., et al. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst. 85:1993;200-206
20. Valentinis B., Baserga R. IGF-I receptor signaling in transformation and differentiation. Mol Pathol. 54:2001;133-137
21. Hallak H., Moehren G., Tang J., et al. Epidermal growth factor-induced activation of the insulin-like growth factor I receptor in rat hepatocytes. Hepatology. 36:2002;1509-1518
22. Rubin R., Baserga R. Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity. Lab Invest. 73:1995;311-331
23. Furstenberger G., Senn H.J. Insulin-like growth factors and cancer. Lancet Oncol. 3:2002;298-302
24. Grimberg A., Cohen P. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol. 183:2000;1-9
25. Sell C., Dumenil G., Deveaud C., et al. Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts. Mol Cell Biol. 14:1994;3604-3612
26. Mauro L., Salerno M., Morelli C., et al. Role of the IGF-I receptor in the regulation of cell-cell adhesion Implications in cancer development and progression. J Cell Physiol. 194:2003;108-116
27. Zeigler M.E., Krause S., Karmiol S., et al. Growth factor-induced epidermal invasion of the dermis in human skin organ culture Dermal invasion correlated with epithelial cell motility. Invasion Metastasis. 16:1996;3-10
28. Long L., Rubin R., Baserga R., et al. Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor receptor. Cancer Res. 55:1995;1006-1009
29. Resnicoff M., Abraham D., Yutanawiboonchai W., et al. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res. 55:1995;2463-2469
30. O'Connor R., Kauffmann-Zeh A., Liu Y., et al. Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis. Mol Cell Biol. 17:1997;427-435
31. Liu J.P., Baker J., Perkins A.S., et al. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell. 75:1993;59-72
32. Doerr M.E., Jones J.I. The roles of integrins and extracellular matrix proteins in the insulin-like growth factor I-stimulated chemotaxis of human breast cancer cells. J Biol Chem. 271:1996;2443-2447
33. Dunn S.E., Ehrlich M., Sharp N.J., et al. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer. Cancer Res. 58:1998;3353-3361
34. Long L., Navab R., Brodt P. Regulation of the Mr 72,000 type IV collagenase by the type I insulin-like growth factor receptor. Cancer Res. 58:1998;3243-3247
35. Andre F., Rigot V., Thimonier J., et al. Integrins and E-cadherin cooperate with IGF-I to induce migration of epithelial colonic cells. Int J Cancer. 83:1999;497-505
36. Surmacz E. Function of the IGF-I receptor in breast cancer. J Mammary Gland Biol Neoplasia. 5:2000;95-105
37. Djavan B., Waldert M., Seitz C., et al. Insulin-like growth factors and prostate cancer. World J Urol. 19:2001;225-233
38. Nickerson T., Chang F., Lorimer D., et al. In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR). Cancer Res. 61:2001;6276-6280
39. Hakam A., Fang Q., Karl R., et al. Coexpression of IGF-1R and c-Src proteins in human pancreatic ductal adenocarcinoma. Dig Dis Sci. 48:2003;1972-1978
40. Wu X., Yu H., Amos C.I., et al. Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk. J Natl Cancer Inst. 92:2000;737-743
41. Sekharam M., Zhao H., Sun M., et al. Insulin-like growth factor 1 receptor enhances invasion and induces resistance to apoptosis of colon cancer cells through the Akt/Bcl-x(L) pathway. Cancer Res. 63:2003;7708-7716
42. Scharf J.G., Dombrowski F., Ramadori G. The IGF axis and hepatocarcinogenesis. Mol Pathol. 54:2001;138-144
43. Burroughs K.D., Howe S.R., Okubo Y., et al. Dysregulation of IGF-I signaling in uterine leiomyoma. J Endocrinol. 172:2002;83-93
44. Druckmann R., Rohr U.D. IGF-1 in gynecology and obstetrics Update 2002. Maturitas. 41:(Suppl 1):2002;S65-S83
45. Zumkeller W., Westphal M. The IGF/IGFBP system in CNS malignancy. Mol Pathol. 54:2001;227-229
46. Hursting S.D., Perkins S.N., Phang J.M., et al. Diet and cancer prevention studies in p53-deficient mice. J Nutr. 131:(Suppl 11):2001;3092S-3094S
47. Vella V., Sciacca L., Pandini G., et al. The IGF system in thyroid cancer New concepts. Mol Pathol. 54:2001;121-124
48. Weber M.M., Fottner C., Wolf E. The role of the insulin-like growth factor system in adrenocortical tumorigenesis. Eur J Clin Invest. 30:(Suppl 3):2000;69-75
49. Lohse C.M., Blute M.L., Zincke H., et al. Comparison of standardized and nonstandardized nuclear grade of renal cell carcinoma to predict outcome among 2,042 patients. Am J Clin Pathol. 118:2002;877-886
50. Werner H., Roberts C.T. Jr. The IGFI receptor gene A molecular target for disrupted transcription factors. Genes Chromosomes Cancer. 36:2003;113-120
51. Andrews D.W., Resnicoff M., Flanders A.E., et al. Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas. J Clin Oncol. 19:2001;2189-2200
52. Benini S., Manara M.C., Baldini N., et al. Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cells. Clin Cancer Res. 7:2001;1790-1797
53. Perer E.S., Madan A.K., Shurin A., et al. Insulin-like growth factor I receptor antagonism augments response to chemoradiation therapy in colon cancer cells. J Surg Res. 94:2000;1-5